Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Asthenia | 13% | 14% | x | x |
| Abdominal pain | 9% | 11% | x | x |
| Headache | 9% | 10% | x | x |
| Nausea | 5% | 8% | x | x |
| Flatulence | 4% | 4% | x | x |
| Diarrhoea | 3% | 4% | x | x |
| Dyspepsia | 3% | 2% | x | x |
| Connective tissue disorder | postmarketing | x | x | |
| Fanconi syndrome | postmarketing | x | x | |
| Fracture | postmarketing | x | ||
| Gastrointestinal disorder | postmarketing | x | x | |
| Myopathy | postmarketing | x | x | |
| Osteomalacia | postmarketing | x | x | |
| Pancreatitis | postmarketing | x | x | |
| Renal failure | postmarketing | x | x | |
| Urinary tract disorder | postmarketing | x | x | |
| Hypophosphataemia | postmarketing | x | x | |
| Bone pain | postmarketing | x | ||
| Malnutrition | postmarketing | x | x | |
| Rash | x | x | ||
| Hepatitis | x | x | ||
| Pruritus | x | x | ||
| Vomiting | x | x | ||
| Creatinine increased | x | x | ||
| Kidney function abnormal | x | x | ||
| Nephrotoxicity | x | x | ||
| Serum creatinine increased | x | x | ||
| Phosphorus low | x | x | ||
| Renal impairment | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |